Nephera
Misgav, HaZafon, Israel
About Nephera
Nephera (Israeli) a development-stage medical device company focused on kidney function in CHF patients. Nephera offers a treatment for acute heart failure patients by protecting kidney function through the modulation of sympathetic nerve activity. The company’s unique technology, in the exciting field of neurohormonal modulation, is based on electrical stimulation of the urinary tract for controlled inhibition of renal sympathetic nerve activity. The clinical outcome is preserved renal function and enhanced diuretic therapy.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2010)
- Website: nephera.com
- Phone: +972 4 999 1991
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nephera-2471503 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.